Robert J. Leadley

2.2k total citations
62 papers, 1.6k citations indexed

About

Robert J. Leadley is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Robert J. Leadley has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 30 papers in Hematology and 14 papers in Internal Medicine. Recurrent topics in Robert J. Leadley's work include Blood Coagulation and Thrombosis Mechanisms (28 papers), Atrial Fibrillation Management and Outcomes (24 papers) and Venous Thromboembolism Diagnosis and Management (14 papers). Robert J. Leadley is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (28 papers), Atrial Fibrillation Management and Outcomes (24 papers) and Venous Thromboembolism Diagnosis and Management (14 papers). Robert J. Leadley collaborates with scholars based in United States, Switzerland and Norway. Robert J. Leadley's co-authors include K. L. Goetz, Jia L. Zhu, Jeffrey B. Madwed, Alison W. Gagnon, Mark H. Perrone, Christopher T. Dunwiddie, Peter Bie, Sam Rebello, Charles Kasiewski and Ross Bentley and has published in prestigious journals such as Circulation, Blood and Biochemistry.

In The Last Decade

Robert J. Leadley

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Leadley United States 21 693 372 334 300 214 62 1.6k
Peter Presek Germany 25 335 0.5× 476 1.3× 773 2.3× 119 0.4× 258 1.2× 49 2.0k
A. Bernat France 23 874 1.3× 704 1.9× 334 1.0× 46 0.2× 568 2.7× 68 2.0k
John C. Kermode United States 16 120 0.2× 250 0.7× 432 1.3× 70 0.2× 250 1.2× 40 1.2k
Abel L. Robertson United States 23 529 0.8× 119 0.3× 594 1.8× 205 0.7× 409 1.9× 52 2.1k
White Jg United States 20 117 0.2× 358 1.0× 225 0.7× 140 0.5× 103 0.5× 56 970
Takeo Tanaka Japan 25 360 0.5× 41 0.1× 611 1.8× 179 0.6× 253 1.2× 82 1.6k
U. Pleiß Germany 11 371 0.5× 42 0.1× 509 1.5× 466 1.6× 72 0.3× 36 1.6k
David M. Smalley United States 19 221 0.3× 207 0.6× 807 2.4× 384 1.3× 196 0.9× 33 1.8k
Oliver Speer Switzerland 27 96 0.1× 216 0.6× 746 2.2× 366 1.2× 102 0.5× 49 1.8k
N. Crawford United Kingdom 21 120 0.2× 240 0.6× 702 2.1× 186 0.6× 180 0.8× 75 1.5k

Countries citing papers authored by Robert J. Leadley

Since Specialization
Citations

This map shows the geographic impact of Robert J. Leadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Leadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Leadley more than expected).

Fields of papers citing papers by Robert J. Leadley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Leadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Leadley. The network helps show where Robert J. Leadley may publish in the future.

Co-authorship network of co-authors of Robert J. Leadley

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Leadley. A scholar is included among the top collaborators of Robert J. Leadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Leadley. Robert J. Leadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casimiro‐Garcia, Agustin, Christopher F. Bigge, Wayne L. Cody, et al.. (2009). Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action. Bioorganic & Medicinal Chemistry. 17(6). 2501–2511. 17 indexed citations
2.
Major, Terry C., Wendy S. Rosebury, Carlin V. Okerberg, et al.. (2008). A Nonpeptide, Piperidine Renin Inhibitor Provides Renal and Cardiac Protection in Double-Transgenic Mice Expressing Human Renin and Angiotensinogen Genes. Cardiovascular Drugs and Therapy. 22(6). 469–478. 7 indexed citations
3.
Baxi, Sangita M., et al.. (2005). Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. Journal of Thrombosis and Haemostasis. 3(4). 733–741. 85 indexed citations
4.
Gibson, G. R., et al.. (2004). Characterization of a tissue factor/factor VIIa‐dependent model of thrombosis in hypercholesterolemic rabbits. Journal of Thrombosis and Haemostasis. 2(1). 85–92. 18 indexed citations
5.
Chi, Liguo, Glenn Gibson, Thomas Mertz, et al.. (2004). In Vitro and In Vivo Antithrombotic Activity of PD-198961, a Novel Synthetic Factor Xa Inhibitor. Journal of Cardiovascular Pharmacology. 44(4). 493–500. 7 indexed citations
6.
Shebuski, Ronald J., Larry R. Bush, Alison W. Gagnon, Liguo Chi, & Robert J. Leadley. (2004). Development and Applications of Animal Models of Thrombosis. Humana Press eBooks. 93. 175–220. 6 indexed citations
7.
Karnicki, Krzysztof, Robert D. McBane, Robert J. Leadley, et al.. (2004). Inhibition and reversal of platelet‐rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition. Journal of Thrombosis and Haemostasis. 2(12). 2162–2169. 8 indexed citations
8.
Bilder, Glenda E., Dilip Amin, Lisa Morgan, et al.. (2003). Stent-induced Restenosis in the Swine Coronary Artery Is Inhibited by a Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, TKI963. Journal of Cardiovascular Pharmacology. 41(6). 817–829. 8 indexed citations
9.
Gagnon, Alison W., David Murray, & Robert J. Leadley. (2002). Cloning and characterization of a novel regulator of G protein signalling in human platelets. Cellular Signalling. 14(7). 595–606. 41 indexed citations
10.
Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations
11.
Rebello, Sam, Charles Kasiewski, Ross Bentley, et al.. (2001). Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs. Thrombosis Research. 102(3). 261–271. 13 indexed citations
12.
Leadley, Robert J.. (2001). Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases. Current Opinion in Pharmacology. 1(2). 169–175. 17 indexed citations
13.
Rebello, Sam, Charles Kasiewski, Wei Wang, et al.. (2001). Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs. Journal of Cardiovascular Pharmacology. 38(2). 288–297. 9 indexed citations
14.
Leadley, Robert J., Liguo Chi, Sam Rebello, & Alison W. Gagnon. (2000). Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. Journal of Pharmacological and Toxicological Methods. 43(2). 101–116. 75 indexed citations
15.
Heran, Christopher L., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (2000). Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis. European Journal of Pharmacology. 389(2-3). 201–207. 23 indexed citations
16.
Becker, Michael R., William R. Ewing, Henry W. Pauls, et al.. (1999). Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(18). 2753–2758. 19 indexed citations
17.
Zhu, Jia L. & Robert J. Leadley. (1995). Contribution of Cardiac and Arterial Baroreceptors to Enhanced Vasopressin Release During Hemorrhage with Autonomic Blockade. Experimental Biology and Medicine. 208(4). 361–369. 1 indexed citations
18.
Leadley, Robert J., et al.. (1990). Atriopeptin Alters the Vasopressin and Renin Responses Elicited by Hemorrhage. Experimental Biology and Medicine. 193(2). 85–91. 1 indexed citations
19.
Zhu, Jia L., et al.. (1990). Norepinephrine-induced atriopeptin release in conscious dogs is mediated by alterations in atrial pressure. Life Sciences. 46(2). 139–145. 4 indexed citations
20.
Goetz, K. L., et al.. (1989). Endothelin and Sarafotoxin Produce Dissimilar Effects on Renal Blood Flow, But Both Block the Antidiuretic Effects of Vasopressin. Experimental Biology and Medicine. 191(4). 425–427. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026